Sign In | Join Free | My himfr.com
Home > Cardiac Testing Kit >

PCR Rapid Used For Quantitative Determinatione Of D-Dimer ISO Approved

WWHS Biotech.Inc(exclusive marketed by Dawin)
Contact Now
    Buy cheap PCR Rapid Used For Quantitative Determinatione Of D-Dimer ISO Approved from wholesalers
     
    Buy cheap PCR Rapid Used For Quantitative Determinatione Of D-Dimer ISO Approved from wholesalers
    • Buy cheap PCR Rapid Used For Quantitative Determinatione Of D-Dimer ISO Approved from wholesalers
    • Buy cheap PCR Rapid Used For Quantitative Determinatione Of D-Dimer ISO Approved from wholesalers
    • Buy cheap PCR Rapid Used For Quantitative Determinatione Of D-Dimer ISO Approved from wholesalers

    PCR Rapid Used For Quantitative Determinatione Of D-Dimer ISO Approved

    Ask Lasest Price
    Brand Name : WWHS
    Model Number : D-Dimer
    Certification : ISO 13485, CE
    Price : Negotiable
    Payment Terms : L/C, T/T
    Supply Ability : 20000 Kits per Week
    Delivery Time : 7 Days
    • Product Details
    • Company Profile

    PCR Rapid Used For Quantitative Determinatione Of D-Dimer ISO Approved

    【Product name】D-Dimer.pdf

    D-Dimer Rapid Quantitative Test(Fluorescence immunoassay)


    【Package specification】

    20 Tests/box


    【Intended use】

    This kit is used for quantitative determination of D-dimer in human whole blood and plasma.


    【Storage conditions and validity】

    The test card should be stored at 4℃~30℃, dry, dark and no freezing. It should be stored in sealed aluminum foil bag and valid for 12 months. The test card should be returned to room temperature (15℃~30℃) before opening. It should be used within 15 minutes after unsealing under the environment of 15℃~30℃ and 20% ~ 90% relative humidity.

    The production date, batch number and expiration date are shown in the outer package of the product.

    【Applicable instruments】

    NIR-1000 dry fluoroimmunoassay analyser produced by WWHS Biotech. Inc.


    【Procedure】

    1. Before the test, please read the instructions completely. If the test card and sample are stored in cold storage, they should be balanced at room temperature (15-30)℃ for not less than 30min before use.
    2. Start NIR-1000 dry fluoroimmunoassay analyser according to the instruction manual of the instrument, and carry out quality control verification according to the instruction manual of the instrument(Note: the reagent has been calibrated in advance, and the calibration curve parameters of each batch of reagent have been stored in the information card. The information card is inserted before use, so it is not necessary to calibrate again, and the test can be carried out only after the quality control is passed; Otherwise, the cause should be found out before testing.)
    3. Remove the test card from the aluminum foil bag and use it within 15 minutes.
    4. Place the test card on a clean horizontal table and mark it horizontally.
    5. Mix 10 µL of patient sample with 300µL of sample diluent. Apply 100 µL of diluted samples to the well of the test card.
    6. Insert the test card into NIR-1000 dry fluoroimmunoassay analyser, press the [timing detection] key, automatically time for 10 minutes, automatically judge the test results, and display the quantitative results on the screen. Or insert the test card into the analyzer after timing for 10 minutes, and press the [real time detection] key, and the instrument will automatically interpret the test results.

    【Reference interval】

    By measuring 268 healthy people aged between 19 and 79, statistical analysis shows that the reference interval is less than 500 ng/ml. According to the characteristics of the local population, the reference intervals of the laboratories were established.

    【Interpretation of results】

    1. This reagent is only used for auxiliary detection. If the test results are abnormal, it should be reviewed in time and judged in combination with clinical symptoms.
    2. For samples with D-dimer concentration lower than 40ng/ml and higher than 10000ng/ml, the detection results are reported as "< 40ng/ml" and "> 10000ng /ml", respectively.

    1. Analysis sensitivity

    No more than 40ng/ml.

    2. Accuracy

    The relative deviation from the target value is within ±15%.

    3. Precision

    The within and between assay coefficient of variations are within 15%.

    4. Linear range

    Within the linear range (40 ~ 10000ng/ml), the linear correlation coefficient R≥0.990.



    WWHS Assay list     
    Cardiac     
    cat#.Product itemSpecimenReaction TimeMeasure RangeClinical RangeItended Use
    1cTnIWB/Serum/Plasma12min.0.1-40ng/ml<0.3ng/mlseveral heart diseases including myocardial infarction and heart failure.
    2MyoWB/Serum/Plasma12min.5-400ng/ml<58ng/mlacute myocardial infarction (AMI) in early stage.
    3CK-MBWB/Serum/Plasma12min.1-200ng/ml<5ng/mlacute myocardial infarction (AMI) in early stage.
    4NT-proBNPWB/Serum/Plasma10min.20-35000pg/mlUnder 75:0~347pg/mL,
    Over 75:0~449pg/mL
    heart failure .
    5D-DimerWB/Plasma10min.40-10000ng/ml<500ng/mldisseminated intravascular coagulation (DIC),deep vein thrombosis (DVT),pulmonary embolism (PE), myocardial infarction, cerebral infarction, etc.
    6cTnI+Myo+CKMBWB/Serum/Plasma12min.same with single itemsame with single itemTriple marker of myocardial infarction.
    7ST2WB/Serum/Plasma10min.10-400ng/ml<35ng/mlheart failure .
    8Lp-PLA2WB/Serum/Plasma10min.10-900ng/ml<175ng/mlRisk evaluation of ACS and atherosclerotic ischemic stroke patients.
    9S100-βWB/Serum/Plasma10min.0.05-10ng/ml<0.2ng/mlCerebral infarction, cerebral injury.
    Inflammation     
    10CRP / hs-CRPWB/Serum/Plasma3min.0.5-200mg/LCRP<10mg/L,hs-CRP<1mg/Lnonspecficity inflammatory marker.
    11SAASerum5min.1-200mg/L<10mg/Linflammation&infection.
    12PCTWB/Serum/Plasma10min.0.2-100ng/ml<0.5ng/mlSepsis
    13CRP+SAAWB/Serum/Plasma5min.same with single itemsame with single iteminflammation&infection.
    14IL-6WB/Serum/Plasma10min.5-4000pg/ml10pg/mldiabetes,rheumatoid arthritis,etc
    Thyroid Hormone     
    15TSHSerum/Plasma15min.0.3-100mU/L0.35-5mU/Lhyperthyroidism and hypothyroidism
    16TT3Serum/Plasma15min.0.5-10nmol/L1.3-3.1nmol/Lthyroid dysfunction
    17TT4Serum/Plasma15min.5-300nmol/L66-181nmol/Lthyroid dysfunction
    18FT3Serum/Plasma15min.1-100pmol/L4-10pmol/Lthyroid dysfunction
    19FT4Serum/Plasma15min.5-300pmol/L19-39pmol/Lthyroid dysfunction
    Tumor Marker     
    20AFPSerum/Plasma15min.2.5-200ng/ml<20ng/mlpregnancy cancer
    21CEASerum/Plasma15min.1-200ng/ml<5ng/mlcolon cancer, colorectal cancer,etc.
    22NSESerum/Plasma15min.1-400ng/ml<16ng/mlnon-small cell lung cancer
    23FOBfecal specimens10min.50-1000ng/ml<100ng/mlAbnormal recessive gastrointestinal bleeding
    24PG IISerum/Plasma15min.1-100ug/LPGI/PGII>3.0gastric abnormalities
    25PG ISerum/Plasma15min.2.5-200ug/L>70ng/mlgastric abnormalities
    26TPSASerum/Plasma15min.0.5-40ng/ml<4ng/mlprostate cancer
    27FPSASerum/Plasma15min.0.1-10ng/ml<1ng/mlprostate cancer
    28CA12-5Serum/Plasma15min.20-500U/ml<35U/mlovarian cancer
    29CA15-3Serum/Plasma15min.10-400U/ml< 25 U/mLbreast cancer
    30HE4Serum/Plasma15min.50-2000pmol/L<140 pmol/Lovarian cancer
    31CA19-9Serum/Plasma15min.10-400U/ml< 27 U/mLpancreatic cancer
    32β-HCGSerum/Plasma15min.5-400mIU/ml<10 mIU/mLEarly pregrancy, ectopic HCG cancer,incomplete abortion
    33CK19(Cyfra21-1)Serum/Plasma15min.0.5-50ng/ml<2.5ng/mlnon-small cell lung cancer
    Fertility     
    34HCG / β-HCGSerum/Plasma10min.5-20000mIU/ml<5 mIU/mLearly pregrancy.
    35AMHSerum/Plasma10min.0.1-16ng/mlMale: 20-60 years old, 0.92-13.89 ng/mL
    Female: 20-29 years old, 0.88-10.35 ng/mL
    30-39 years old, 0.31-7.86 ng/mL 40 -50 years old, <5. 07 ng/mL
    ovarian reserve level
    Gastrointestinal      
    36FOBfecal specimens10min.qualitativequalitativegastrointestinal hemorrhage.
    37TRFfecal specimens10min.qualitativequalitativegastrointestinal hemorrhage.
    38FOB+TRFfecal specimens10min.qualitativequalitativegastrointestinal hemorrhage.
    Infection      
    39C.PneumoniaWB/Serum/Plasma15min.qualitativequalitativeCP infection
    40M.PneumoniaWB/Serum/Plasma15min.qualitativequalitativeMP infection
    41Covid-19 Antigennasal swab, throat swab or nasal wash/aspirate specimens15min.qualitativequalitativerespiratory tract
    42Covid-19 Ab IgG/IgMWB/Serum/Plasma15min.qualitativequalitativerespiratory tract
    43FluAnasal swab, throat swab or nasal wash/aspirate specimens15min.qualitativequalitativerespiratory tract
    44FluBnasal swab, throat swab or nasal wash/aspirate specimens15min.qualitativequalitativerespiratory tract
    Renal Injury      
    45CysCWB/Serum/Plasma5min.0.4-9mg/L0.5-1.1mg/Lrenal function
    46NGALUrine10min.10-1500ng/mL<132ng/mLacute kidney injury.
    Other      
    47FERRSerum5min.10-500ng/mlMale:24ng/mL~335ng/mL,
    Female:11ng/mL~307ng/mL
    iron metabolism related diseases, such as hemochromatosis and iron deficiency anemia
    48HbA1cWB10min.4%-14%4%-6%diabetes
    49VDSerum/Plasma15min.8-70ng/mL19-57ng/mLfetation

    Quality PCR Rapid Used For Quantitative Determinatione Of D-Dimer ISO Approved for sale
    Inquiry Cart 0
    Send your message to this supplier
     
    *From:
    *To: WWHS Biotech.Inc(exclusive marketed by Dawin)
    *Subject:
    *Message:
    Characters Remaining: (0/3000)